These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12426007)

  • 21. [Treatment of panic disorders and agoraphobia. Psychotherapy, psychopharmacotherapy and their combination].
    Frommberger U; Angenendt J; Berger M
    Nervenarzt; 1995 Mar; 66(3):173-86. PubMed ID: 7753242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of the Therapeutic Relationship in Psychopharmacological Treatment Outcomes: A Meta-analytic Review.
    Totura CMW; Fields SA; Karver MS
    Psychiatr Serv; 2018 Jan; 69(1):41-47. PubMed ID: 28945182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A critical account of the current approach to education in clinical psychopharmacology.
    Loga S; Loga-Zec S; Sošić B
    Psychiatr Danub; 2011 Sep; 23(3):289-92. PubMed ID: 21963699
    [No Abstract]   [Full Text] [Related]  

  • 24. [How many children and adolescents do receive a combined behavioral and psychopharmacological therapy?].
    Sinzig J; Blanz S; Schmidt MH; Lehmkuhl G
    Prax Kinderpsychol Kinderpsychiatr; 2008; 57(2):85-97. PubMed ID: 18396847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementing integrated treatment for co-existing substance use and severe mental health problems in assertive outreach teams: training issues.
    Graham HL
    Drug Alcohol Rev; 2004 Dec; 23(4):463-70. PubMed ID: 15763751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Adherence to psychopharmacological treatment: Psychotherapeutic strategies to enhance adherence].
    Lencer R; Korn D
    Nervenarzt; 2015 May; 86(5):637-46; quiz 647-8. PubMed ID: 25903501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of behavioral tailoring strategies for improving medication adherence in serious mental illness.
    Kreyenbuhl J; Record EJ; Palmer-Bacon J
    Dialogues Clin Neurosci; 2016 Jun; 18(2):191-201. PubMed ID: 27489459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Special feature: personality disorders: models for treatment and strategies for treatment development.
    Benjamin LS
    J Pers Disord; 1997; 11(4):307-24. PubMed ID: 9484693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Psychopharmacological treatment of suicidal process].
    Mussa A
    Vertex; 2011; 22(100):435-43. PubMed ID: 22799145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of psychopathology in people with intellectual and other disabilities.
    Sturmey P
    Can J Psychiatry; 2012 Oct; 57(10):593-600. PubMed ID: 23072950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Possibilities and limitations of psychopharmacological treatments in patients with psychological comorbidity].
    Laux G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jan; 54(1):37-45. PubMed ID: 21246327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of behavioral problems in intellectually disabled adult patients with epilepsy.
    Kerr M; Gil-Nagel A; Glynn M; Mula M; Thompson R; Zuberi SM
    Epilepsia; 2013 Mar; 54 Suppl 1():34-40. PubMed ID: 23458464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of problem behaviour during medication evaluations.
    Zarcone J; Napolitano D; Valdovinos M
    J Intellect Disabil Res; 2008 Dec; 52(12):1015-28. PubMed ID: 18717764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychopharmacology training in psychiatric residency programs: the Canadian scene.
    Awad AG; Darby PL; Garfinkel PE
    Can J Psychiatry; 1991 Feb; 36(1):21-5. PubMed ID: 2029679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the Self-Disclosure Process in Peer Mentoring Relationships for Transition-Age Youth With Developmental Disabilities.
    Ryan CT; Kramer JM; Cohn ES
    Intellect Dev Disabil; 2016 Aug; 54(4):245-59. PubMed ID: 27494124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mindfulness and bodily distress.
    Fjorback LO
    Dan Med J; 2012 Nov; 59(11):B4547. PubMed ID: 23171754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of empirical evidence of somatic treatment options for the MI/DD population.
    Ulzen TP; Powers RE
    Psychiatr Q; 2008 Sep; 79(3):265-73. PubMed ID: 18726159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychotherapy research. Clinical trials versus clinical reality.
    Fava GA
    Psychother Psychosom; 1986; 46(1-2):6-12. PubMed ID: 3299448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated collaborative care teams to enhance service delivery to youth with mental health and substance use challenges: protocol for a pragmatic randomised controlled trial.
    Henderson JL; Cheung A; Cleverley K; Chaim G; Moretti ME; de Oliveira C; Hawke LD; Willan AR; O'Brien D; Heffernan O; Herzog T; Courey L; McDonald H; Grant E; Szatmari P
    BMJ Open; 2017 Feb; 7(2):e014080. PubMed ID: 28167747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychopharmacotherapy in children and adults with intellectual disability.
    Santosh PJ; Baird G
    Lancet; 1999 Jul; 354(9174):233-42. PubMed ID: 10421318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.